Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.93 and traded as high as $2.95. Mesoblast shares last traded at $2.20, with a volume of 6,144 shares changing hands.
Mesoblast Price Performance
The company’s fifty day moving average is $1.28 and its two-hundred day moving average is $0.93.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Read More
- Five stocks we like better than Mesoblast
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Are Penny Stocks a Good Fit for Your Portfolio?
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Stock Splits, Do They Really Impact Investors?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
